The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
about
Sirtuin functions and modulation: from chemistry to the clinicBiodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenograftsBlocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation.Role of SIRT1-mediated mitochondrial and Akt pathways in glioblastoma cell death induced by Cotinus coggygria flavonoid nanoliposomesVorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancerSensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cellsCervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Sirtuin activators and inhibitors.Sirtuin inhibitors as anticancer agents.miRNAs and ovarian cancer: a miRiad of mechanisms to induce cisplatin drug resistance.Treatment of etoposide combined with 15-deoxy-Δ(12,14)-prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferator-activated receptor-γ-independent pathways.Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.Histone Deacetylase Inhibitor SAHA as Potential Targeted Therapy Agent for Larynx Cancer CellsVPA does not enhance platinum binding to DNA in cisplatin-resistant neuroblastoma cancer cells.Synergistic antitumor effect of suberoylanilide hydroxamic acid and cisplatin in osteosarcoma cellsCurrent Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
P2860
Q26745884-B3CE1621-9EE2-44A0-8843-1DB542587357Q28482418-EE60B71E-25DC-44BA-B23A-52136166FC40Q33943997-C958A4FE-A12D-4C65-92EE-CF8ABF7E189BQ34618963-2CD39F09-6318-420C-BB8A-0BDEBDEF00DEQ35934956-A26D6815-E479-42C9-BD79-257994AD3005Q36184617-AFB3B804-DCE5-47F7-B501-34E68D7A780FQ36537920-DFEF4CD5-4CCC-45EE-916E-EC8A0524A515Q37520579-9462E42C-BE6E-41A3-A5D8-D911FE2A4FF5Q37579334-A2D55AE8-7A65-4432-A820-D1BF1CE30F42Q38021431-8BD7F4EC-07D6-49BB-86AC-884360C37C55Q38223016-37BFA030-2BC0-4D7C-AE77-DBC9E1A30F03Q38633144-8DA0150B-1F5B-468E-B5F1-E0445C91A4C8Q39013610-4C37B3C7-B04D-4532-B27E-024048FC633CQ41947077-CDE3FBEC-3804-4721-A022-76FC8BA59847Q42328146-58B12E32-8DEE-402C-80E6-F8047F584572Q49849762-17099693-C861-44B1-BCBE-C4C647A164C8Q57922472-E78FBD97-E16B-405B-97CA-0F02E26D8C76Q58588998-5292481E-BD0F-49C9-9C94-D5E2F263ACC2
P2860
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
The effect of combined treatme ...... lase inhibitors on HeLa cells.
@en
type
label
The effect of combined treatme ...... lase inhibitors on HeLa cells.
@en
prefLabel
The effect of combined treatme ...... lase inhibitors on HeLa cells.
@en
P2093
P2860
P1476
The effect of combined treatme ...... lase inhibitors on HeLa cells.
@en
P2093
Eun Joo Noh
Jeong-Yeol Park
Jong-Hyeok Kim
Joo Hak Lee
Joo-Hyun Nam
Ke Long Jin
Kwang Lae Hoe
P2860
P304
P356
10.3802/JGO.2010.21.4.262
P577
2010-12-31T00:00:00Z